Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Amazon's Presence at the Oscars
21:00 - Hollywood's biggest weekend is just around the corner with the 89th annual Academy Awards on Sunday. We see some familiar names like Meryl Streep and Ryan Gosling, but there is one new player grabbing attention. Bloomberg's Kaitlin Meehan reports on “Bloomberg Technology.” (Source: Bloomberg)
  • The Self-Driving Car Fight Between Google and Uber
  • Lucid Motors Aims to Rival Tesla
  • Personal Capital CEO Says Banks Need to Change Attitude